Switch to:

Beam Therapeutics Gross Margin %

: 0.00% (As of Mar. 2020)
View and export this data going back to 2020. Start your Free Trial

Gross Margin % is calculated as gross profit divided by its revenue. Beam Therapeutics's Gross Profit for the three months ended in Mar. 2020 was $0.01 Mil. Beam Therapeutics's Revenue for the three months ended in Mar. 2020 was $0.01 Mil. Therefore, Beam Therapeutics's Gross Margin % for the quarter that ended in Mar. 2020 was 0.00%. If there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.




Beam Therapeutics had a gross margin of N/A% for the quarter that ended in Mar. 2020 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Beam Therapeutics was 0.00% per year.


Beam Therapeutics Gross Margin % Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Beam Therapeutics Annual Data
Dec17 Dec18 Dec19
Gross Margin % 0.00 0.00 0.00

Beam Therapeutics Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
Gross Margin % Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Beam Therapeutics Gross Margin % Distribution

* The bar in red indicates where Beam Therapeutics's Gross Margin % falls into.



Beam Therapeutics Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Beam Therapeutics's Gross Margin for the fiscal year that ended in Dec. 2019 is calculated as

Gross Margin % (A: Dec. 2019 )=Gross Profit (A: Dec. 2019 ) / Revenue (A: Dec. 2019 )
=0 / 0.018
=(Revenue - Cost of Goods Sold) / Revenue
=(0.018 - 0) / 0.018
=N/A %

Beam Therapeutics's Gross Margin for the quarter that ended in Mar. 2020 is calculated as


Gross Margin % (Q: Mar. 2020 )=Gross Profit (Q: Mar. 2020 ) / Revenue (Q: Mar. 2020 )
=0 / 0.006
=(Revenue - Cost of Goods Sold) / Revenue
=(0.006 - 0) / 0.006
=N/A %

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Beam Therapeutics  (NAS:BEAM) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Beam Therapeutics had a gross margin of N/A% for the quarter that ended in Mar. 2020 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Beam Therapeutics Gross Margin % Related Terms


Beam Therapeutics Gross Margin % Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)